Tate & Lyle

Intesa has made a €31 billion bid for Paschi, and Tate & Lyle is involved in a takeover. The events are reported by The Opening Trade on June 8, 2026.

Tate & Lyle has agreed to a £2.7bn takeover by US rival Ingredion, which could result in nearly 500 jobs being at risk globally. The deal represents a significant loss for London's struggling stock market.

Tate & Lyle, a UK-based company producing artificial sweeteners like Splenda, has agreed to a £2.7bn takeover by US rival Ingredion. The deal, valued at 615p per share (60% above pre-takeover prices), could jeopardize nearly 500 global jobs and marks another setback for London's struggling stock market.

British ingredients firm Tate & Lyle was acquired by a US rival in a £2.7 billion deal. The transaction marks a significant corporate acquisition in the food industry.

Tate & Lyle has agreed to a £2.7bn takeover by US rival Ingredion. The deal occurs as the UK-based ingredients company faces challenges from weak consumer spending.

Tate & Lyle, which focuses on sugar replacements and calorie reducers, was sold to a US rival, marking a loss for London. The company is also expanding into dietary fibers.

Ingredion is in advanced talks to acquire Tate & Lyle for £2.7 billion. Tate & Lyle produces a range of ingredients used in baked goods and animal feed.

Hiscox's shares surged to record highs amid reports of a potential takeover bid by Canada's Intact Financial Corp. The UK-based insurer is the latest target in a flurry of overseas bids for British businesses. Intact Financial Corp provides property and casualty insurance.

Tate & Lyle has received an offer of up to £2.7 billion from Ingredion. The company produces ingredients used in various products, including baked goods and animal feed. This offer is a significant development for Tate & Lyle.